Reinterpreting Amitriptyline in Extra-esophageal Gastroesophageal Reflux Disease Through the GABAergic Inhibitory Axis
Journal of Neurogastroenterology and Motility · 30.07.2026 · 32 (3) · 468-469
DOI: 10.5056/jnm26018 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Neurogastroenterology and Motility, erschienen am 30.07.2026. Verfasst von Qing Xiao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Xiaogan Maternal and Child Health Hospital, Xiaogan, Hubei, China. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Xiaogan Maternal and Child Health Hospital, Xiaogan, Hubei, China.
- First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, China.
- Xiaogan hospital affiliated to Wuhan University of Science and Technology, Xiaogan, Hubei, China.
- Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China.
ORCID-Profile: Anlong Yuan, Jun Xiao
Zitieren
APA
Xiao, Q., Li, Z., Yuan, A., & Xiao, J. (2026). Reinterpreting Amitriptyline in Extra-esophageal Gastroesophageal Reflux Disease Through the GABAergic Inhibitory Axis. Journal of Neurogastroenterology and Motility, 32(3), 468-469. https://doi.org/10.5056/jnm26018
Vancouver
Xiao Q, Li Z, Yuan A, Xiao J. Reinterpreting Amitriptyline in Extra-esophageal Gastroesophageal Reflux Disease Through the GABAergic Inhibitory Axis. Journal of Neurogastroenterology and Motility. 2026;32(3):468-469. doi:10.5056/jnm26018
BibTeX
@article{Xiao2026,
author = {Xiao, Qing and Li, Ziwei and Yuan, Anlong and Xiao, Jun},
title = {Reinterpreting Amitriptyline in Extra-esophageal Gastroesophageal Reflux Disease Through the GABAergic Inhibitory Axis},
journal = {Journal of Neurogastroenterology and Motility},
year = {2026},
volume = {32},
number = {3},
pages = {468--469},
doi = {10.5056/jnm26018}
}
EUVIMED